Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC) Deep Dive Video

Summary

ROVI is pivoting from pandemic-era CDMO volatility to durable U.S./EU biologics manufacturing and proprietary long-acting injectables—while racing to de-risk a heparin supply chain tied to China.

View ROVI.MC stock page · Read the ROVI.MC research report

Loading the video player…